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Abstract
Study Objectives: The majority of patients with mental disorders suffer from insomnia, associated with adverse health outcomes. 
Cognitive behavioral therapy for insomnia (CBT-I) represents the first-line treatment, but is too complex for severely ill patients 
and not systematically implemented in inpatient psychiatric care. This project aimed to develop a pragmatic behavioral treatment 
program that empowers inpatients with severe mental disorders to take care of their own sleep health.
Methods: CBT-I was adapted based on implementation research involving 24 inpatients with psychiatric disorders across diagnostic 
entities and comorbid insomnia and 30 health care providers at the University Hospital of Psychiatry and Psychotherapy, Bern. The 
program was implemented and evaluated by 15 patients and 22 health care providers based on interviews and questionnaires before 
participation and prior to discharge.
Results: Implementation research resulted in the SLEEPexpert intervention, centering on bedtime restriction and circadian 
adaptation in three phases; therapist-guided treatment initiation, self-management with nursing support, and self-management. 
Evaluative pre-post assessments in 15 patients demonstrated feasibility. Time in bed decreased by 60 minutes (520 ± 105.3 vs. 460 ± 
78.1, p = 0.031, d = 0.6) and total sleep time increased by around 45 minutes (331 ± 110.6 vs. 375 ± 74.6, p = 0.09, d = 0.5), resulting in 
increased sleep efficiency (65.3 ± 21.8 vs. 81.9 ± 11.2%, p = 0.011, d = 0.8). Patients improved on the Insomnia Severity Index (18.3 ± 4.6 
vs. 11.4 ± 4.4, p < 0.001, d = 1.2) and Pittsburgh Sleep Quality Index (12.9 ± 3.8 vs. 10.3 ± 3.3, p = 0.031, d = 0.6).
Conclusions: We propose a new pragmatic behavioral treatment program (SLEEPexpert) customized to the needs of patients 
and health care providers in inpatient psychiatric care. Data demonstrate feasibility. An improvement of insomnia severity was 
observed, but a control comparison is needed to further test for efficacy.
Key words:  insomnia; psychiatric inpatients; behavioral therapy; implementation research; empowering patients
Statement of Significance
We propose a novel pragmatic behavioral treatment program for insomnia customized to the needs of patients with severe psy-
chiatric disorders. The program translates current treatment guidelines for insomnia to inpatient psychiatric care. It aims to em-
power patients to take care of their own sleep health (“Become your own SLEEPexpert”) and offers an alternative to common medical 
practice, often comprising (over) treatment with pharmacotherapy. Given the high burden of comorbid insomnia in psychiatry, 
further developments might be of health relevance.
Sleep Advances, 2020, 1–8
doi: 10.1093/sleepadvances/zpaa005
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Introduction
Mental disorders are among the leading causes of reduced 
quality of life due to illness worldwide [1]. The majority of pa-
tients with mental disorders suffer from insomnia symptoms 
[2], and around one-third meet diagnostic criteria for insomnia 
disorder (ID) [3]. ID is defined by difficulties falling asleep, 
staying asleep, or early morning awakening associated with im-
paired daytime functioning over a period of at least 3 months 
[4]. Comorbid ID has been shown to worsen the course of mental 
disorders and to reduce quality of life [5]. Current guidelines 
identify cognitive behavioral therapy for insomnia (CBT-I) as 
first-line treatment, usually composed of education, relaxation, 
behavioral change, and cognitive components [6].
Various adaptations of CBT-I for different target groups and 
settings have already been developed. The Brief Behavioral 
Treatment for Insomnia (BBT-I), for example, centers on bed-
time restriction [7]. BBT-I has proven similarly effective as the 
complete program for patients with primary insomnia, somatic 
comorbidity, or minor psychiatric comorbidity [8]. Preliminary 
work in patients with major psychiatric comorbidity sug-
gested feasibility and efficacy of a CBT-I-based psychological 
sleep treatment in outpatient [9] and inpatient settings [10, 11]. 
However, other work described insurmountable obstacles for 
implementing bedtime restriction in inpatient psychiatric care, 
such as limited cooperation of patients and insufficient health 
care resources on the investigated wards [12]. Together, psy-
chological sleep treatments have not been sufficiently adapted 
to the particular needs of inpatients with severe psychiatric 
disorders, often characterized by substantive cognitive, emo-
tional, and behavioral problems [13]. Rather, insomnia in in-
patient psychiatric care often remains untreated or overtreated 
with hypnotics, which bears the risk of adverse effects and 
dependency.
The current project aimed to develop a pragmatic behav-
ioral treatment program that empowers inpatients with severe 
mental disorders to take care of their own sleep health (“Become 
your own SLEEPexpert”). The specific aims were to (1) adapt CBT-I 
to the needs of patients and health care providers in inpatient 
psychiatric care, (2) implement the program on psychiatric 
wards, and (3) provide pilot data on the feasibility of the pro-
gram and changes in sleep and mental health.
Methods
Participants
Twenty-four patients hospitalized due to acute psychiatric dis-
orders and suffering from comorbid insomnia as well as 30 
health care providers, including medical doctors, nurses, and 
psychologists across levels of experience, were involved in the 
development of the program (see Figure 1, A for an overview 
Figure 1. Process and SLEEPexpert treatment components. (A) The SLEEPexpert development phase included design thinking, interviews of patients and health care 
providers, iterative adaptations to the specialized behavior treatment program and training of the nursing teams. The program consists of three phases: (1) Kick-off 
presentation: a therapist-guided treatment initiation, (2) Self-management with nursing support: nurse-assisted self-management of the implementation of sleep-
related behavioral change, and (3) Self-management. (B–D) Surfer imagery used for simple visualization of sleep processes. (B) Sleep pressure (wave) needs to be built 
up prior to sleep (surf). (C) Insufficient buildup results in an inability to sleep (surf). (D) Finally, the right point in time or circadian phase is critical for successful sleep 
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of the program development). Twenty-four patients fulfilling 
diagnostic criteria according to DSM-5 for comorbid ID or acute 
ID were recruited and provided written informed consent. 
Clinical interviews revealed no symptoms of other sleep dis-
orders than insomnia. Of particular note, minimal exclusion 
criteria, such as severe cognitive deficits or acute drug intoxica-
tion, were determined to ensure a typical sample of inpatients 
with acute psychiatric disorders. Demographic and clinical 
characteristics are listed in Table 1. As indices of severity, most 
patients had more than one psychiatric diagnosis and a high 
burden of disease, such as acute hallucinations or a history 
of suicide attempts. Three patients were excluded based on 
clinical judgment by the responsible senior physician (diffi-
culties participating in the group session due to severe rest-
lessness, catatonia with motor inhibition, and severe acoustic 
hallucinations). Patients received treatment as usual, including 
pharmacotherapy informed by current guidelines, adapted to 
individual needs (Supplementary Table 1). Six patients were 
not available to report on their clinical experience due to dis-
charge according to standard clinical procedures, pointing to 
challenges of implementation in an acute psychiatric setting. 
Fifteen patients took part in program evaluation (see Figure 2 
for flow of patients).
The clinical treatment development was reviewed by 
the Bernese Ethics Committee (BASEC-Nr. Req-2020-00340). 
Clarification of responsibility concluded that the present work 
is a clinical development project and did not require ethical 
approval.
Implementation research
Implementation research strategies [14] aiming at decreasing 
the know-do gap were used to promote the translation of CBT-I 
components into inpatient psychiatric care. Patients and health 
care providers were involved to ensure a shared concept and 
feasibility. As Figure 1 illustrates, this included design thinking, 
qualitative-quantitative analyses of semi-structured interviews, 
training of the nursing teams [15] and iterative adaptations of 
the treatment program based on consultations with partici-
pants, information from social media mining, clinical expertise 




Initial interviews were conducted with 24 patients and 30 health 
care providers. Guidelines for this interview were informed by 
clinical experience from authors with different levels of clin-
ical experience (CLS, master student; EH, clinical psychologist; 
CN, chief physician). Interviews with patients and health care 
providers comprised common and group-specific questions 
exploring underlying beliefs and attitudes towards insomnia 
(e.g. relevance of insomnia and preferences for treatment). For 
a detailed description of the interview guidelines, please refer 
to Supplementary Document 1. Evaluative interviews with pa-
tients (n = 15) and health care providers (n = 22) after participa-
tion in the program intended to give insight to the treatment’s 
feasibility. Evaluative guidelines were compiled from a treat-
ment satisfaction questionnaire and a qualitative research 
paper investigating patients’ treatment experiences [17].
Interviews were audiotaped, transcribed, and analyzed ac-
cording to qualitative content analysis as described by Mayring 
[18]. A mixed procedure was selected, combining basic proced-
ures of inductive and deductive analysis. A  coding guideline 
was developed, including typical anchor examples defining the 
categories. Interview recordings were transcribed by the first 
author following a combination of the selective and compre-
hensive protocol system in order to limit transcription only to 
material relevant for the current investigation. Category scoring 
was checked and discussed with the second and last author. 
Finally, the text was coded by material fulfilling pre-defined 
Table 1. Demographic and clinical characteristics of patients
Program start (n = 21) Program evaluation (n = 15)
Sex 13 F, 8 M 9 F, 6 M
Age (years) 36.2 ± 13.8 (19;59) 41.7 ± 12.6 (19;59)
Primary diagnosis (ICD-10) 10F1; 3F2; 11F3; 3F4; 3F5; 4F6; 1F9 9F1; 2F2 10F3; 2F4; 3F5; 1F6; 1F9
Patients with psychiatric comorbidities (n) 13 9
Duration of mental disorder (years) 13.9 ± 13.4 (1;49) 15.1 ± 15.6 (1;49)
Duration of current hospitalization (days) 49.1 ± 37.6 (7;151) 58.2 ± 38.7 (7;151)
Number of prior hospitalizations (n) 3.6 ± 4.5 (0;20) 3.3 ± 2.6 (0;8)
History of substance use disorder (%) 62% 60%
History of suicide attempts (%) 43% 40%
History of self-harm (%) 38% 27%
Duration of insomnia (years) 13.6 ± 15.3 (0.1;50) 16.2 ± 16.9 (0.5;50)
Data represent means ± SD or frequencies. F, female. M, male. F1, substance use disorder. F2, schizophrenia, schizotypal, and delusion disorders. F3, mood (affective) 
disorders. F4, neurotic, stress-related, and somatoform disorders. F5, behavioral syndromes associated with physiological disturbances and physical factors. F6, dis-
orders of adult personality and behavior. F9, Attention deficit hyperactivity disorder according to ICD-10: international statistical classification of  
diseases and related health problems: tenth revision. World Health Organization, 2004. Data is based on clinical records and interviews.
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categories. Inductive category formation allowed for additional 
categories to be formed when new themes emerged during the 
coding process.
Sleep diary
Patients were asked to keep a standard sleep diary throughout 
participation [19].
Questionnaires
Patients were given standard questionnaires before the inter-
vention and prior to discharge (days 17.9 ± 6.7). This included 
the Insomnia Severity Index (ISI [20]), the Pittsburgh Sleep Quality 
Index (PSQI [21]), and the Brief Symptom Inventory (BSI-18 [22]). 
Treatment adherence was measured through monitoring of 
patients’ estimated time in bed (TIB) and total sleep time 
(TST).
Data analysis
Means and standard deviations are reported as descriptive 
values. Paired-samples t-tests compared pre-post values and 




Qualitative content analyses of initial interviews in 24 patients 
resulted in four categories best representing the data (Figure 3). 
The interviews highlighted insomnia to be a highly relevant 
topic (Panel A) and a preference for non-pharmacological in-
somnia treatment (Panel B). Most patients believe their mental 
disorder to be a possible source of their insomnia, followed by 
Figure 3. Initial interviews. Histogram panels represent relevant themes mentioned by inpatients during the interview prior to treatment. Interview material was 
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dysfunctional thoughts (“I can’t stop ruminating during bedtime”) 
and stress (“I feel a constant pressure is the biggest burden on me”) 
(Panel C). Furthermore, the majority of patients reported ex-
haustion as a result of insomnia affecting their emotional state, 
followed by dysfunctional thoughts and irritability (Panel D). 
When asked what they expected from a specialized insomnia 
treatment, almost all patients expressed a need for help “beyond 
tips and tricks in form of sleep hygiene.”
Initial interviews in 30 health care providers emphasize 
the need for a specialized insomnia treatment due to the high 
prevalence, negative impact, and additional work-load insomnia 
poses on daily ward routines. Furthermore, the overall success 
of standard treatment is perceived to be limited due to pa-
tients’ extended bedtimes. A broad consensus amongst health 
care providers was the wish to reduce overtreatment with 
sleep medication; however, they felt a lack of alternative due 
to limited resources (available non-medicinal treatment, know-
ledge, and training). The nursing team reported confidence in 
the feasibility of integrating pragmatic treatment components 
into a daily ward routine (two brief interactions with each pa-
tient each week), as well as pointing to challenges such as pa-
tient adherence.
“Become your own SLEEPexpert”: the intervention
Implementation research resulted in a pragmatic treatment pro-
gram (“Become your own SLEEPexpert”) customized to the needs 
of inpatients and health care providers in inpatient psychiatry. 
To secure integration of the program, SLEEPexpert was designed 
to function with existing resources on psychiatric wards. We 
aimed to make SLEEPexpert as compact and simple as possible, 
comprising the most promising components based on current 
literature. SLEEPexpert therefore centers on two evidence-based 
and feasible treatment components, bedtime restriction, and 
circadian adaptation. The human sleep-wake cycle is governed 
by two principle regulatory processes. Bedtime restriction ad-
dresses the homeostatic process and represents the single 
most effective treatment component of CBT-I [23]. Circadian 
adaptation, that is, the adaptation of bedtime to the individual 
chronotype, addresses the circadian process. Other components 
of CBT-I were not selected. Specifically, sleep hygiene has been 
widely implemented in inpatient settings without sufficient 
therapeutic effects. Moreover, relaxation training and cognitive 
restructuring are challenging, resource intense, and not suited 
for all patients due to, for instance, high levels of anxiety or prior 
trauma exposure.
SLEEPexpert was designed to include three phases; (1) 
A  therapist-guided treatment initiation (Kick-off presentation) 
consisting of a 45-minute group therapy session, including a 
simplified introduction of homeostatic and circadian sleep-
wake regulation, the derived interventions (bedtime restriction 
and circadian adaptation), the self-management concept and 
general sleep advice. Bedtime restriction was operationalized as 
an individualized sleep window (i.e. set bedtime) determined in 
two steps: (1) adapting the time in bed to the duration the pa-
tient usually spends asleep at night (e.g. 6 h; never < 5 h) and 
(2) positioning the sleep window respectful of the individual’s 
chronotype (e.g. 11 pm–5 am for early types, 1–7 am for late 
Figure 4. Quantitative results. Colored lines represent the same individual patient (n = 15) across panels. Bold black dotted line represents the change in mean score 
of each respective measure. (A) Insomnia Severity Index (ISI). ISI score ≥ 8 suggests clinically relevant insomnia. ***<0.001 (d = 1.2). (B) Pittsburgh Sleep Quality Index 
(PSQI). PSQI score ≥ 5 indicates limited sleep quality. *0.031 (d = 0.6). (C) Sleep efficiency, *0.01 (d = 0.8). (D) Time in bed (TIB) as reported prior to the intervention and 
prescribed in the kick-off session. ***<0.001 (d = 1.3). (E) TIB as reported prior to and after the intervention. Please note that the similarity to panel D indicates adherence 
to the prescribed sleep window. *0.031 (d = 0.6). (F) Total sleep time (TST) reported prior to and after the intervention derived from the PSQI. *<0.1 (d = 0.5). T-tests for 
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types). In contrast to standard procedures (sleep window based 
on sleep diary entries over a 2-week period), the sleep window 
here was determined during the kick-off session based on pa-
tient reports and therapist feedback (TIB, TST, chronotype, etc.) 
to circumvent substantial delays in the acute care setting. The 
individual sleep window was then prescribed by a physician and 
documented in the electronic patient record. Of note, the thera-
peutic content is presented in simple language and metaphors, 
such as the sleep surfer. This metaphor allows for uniform ex-
planation of both homeostatic and circadian aspects of sleep 
regulation to patients (Figure 1, B–D).
(2) Patient self-management with nursing support constitutes 
the second phase. Broad clinical experience in inpatient psychi-
atric care point to the importance of patient empowerment by 
health care providers, making coaching by nursing teams an es-
sential treatment component. Nurse-assisted self-management 
therefore included two brief (1–10 min) individual interactions 
with each patient per week (and additional advice according 
to clinical routines). These interactions centered on explan-
ation, motivation, and adaptation of the sleep window, as well 
as preparing the patient for independent self-management. The 
contact used existing resources, ensuring implementation into 
routine care. SLEEPexpert serves to guide the contact between 
health care providers and patients with insomnia, thereby 
reducing the need of turning to hypnotics when patients re-
port difficulties falling asleep. The individually prescribed sleep 
window can be adjusted through evaluation of the sleep diary 
and in accordance with the patient. The sleep window can be 
prolonged or shortened by 30 minutes, if sleep efficiency (total 
sleep time/time in bed × 100) is ≥90% or <90%, respectively [6]. 
(3) Patient self-management of sleep-related behavior constitutes 
the final phase and may also commence at discharge from the 
psychiatric hospital.
Feasibility and observation of sleep-related 
improvement
As depicted in Figure 4, both ISI (Panel A, 18.3 ± 4.6 vs. 11.4 ± 4.4, 
t(14) = 4.5, p < 0.001, d = 1.2) and PSQI scores (Panel B, 12.9 ± 3.8 
vs. 10.3 ± 3.3, t(14) = 2.4, p = 0.031, d = 0.6) significantly decreased 
from pre- to post-assessments (n = 15). ISI cutoff scores (Panel A) 
indicate that all patients suffered from insomnia (score ≥ 8) at 
pre-assessment, with most categorized as moderately severe to 
severe insomnia (score ≥ 15). At post-assessment, most patients 
scored below clinically relevant insomnia, with three scoring 
below the insomnia subthreshold (score ≤ 8). Panel C shows 
an increase of sleep efficiency from pre- to post-assessment 
(SE, 65.3% ± 21.8 vs. 81.9% ± 11.2, t(14) = −2.9, p = 0.011, d = 0.8). 
Figure 5. Evaluative interviews. Histogram panels represent themes relevant to the investigation mentioned by inpatients during the evaluative interview following 
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Importantly, data deduced from the PSQI indicates adherence 
to the prescribed sleep window (Panel D and E). The reported 
TIB decreased by about 60 minutes (Panel E, 520 ± 105.3 vs.460 ± 
78.1, t(14) = 2.4, p = 0.031, d = 0.6), while TST (Panel F) increased 
by around 45 minutes (331 ± 110.6 vs. 375 ± 74.6, t(14) = −1.8, 
p = 0.09, d = 0.5). The BSI-18 (data not visualized) showed non-
significant difference (29.1  ± 13.7 vs. 24.0  ± 14.4, t(14)  =  2.1, 
p = 0.055, d = 0.5).
Analyses of pharmacotherapy concluded no systematic in-
crease in sedative medication based on physician judgment 
(Supplementary Table 1). Seven patients had no change in medi-
cation; four patients had an increase in dosage; four patients 
received a decreased dosage with two successfully undergoing 
benzodiazepine withdrawal during the time of observation.
Evaluative interviews
Qualitative content analyses of the evaluative interviews prior 
to discharge (n = 15 patients) resulted in six categories best rep-
resenting the data (Figure 5). The data acquired after the inter-
vention shows that most patients perceived sleep therapy as 
important (Panel A). The therapist-guided treatment initiation, 
including the individually prescribed sleep window, was judged 
as the most helpful component (Panel B). Few patients reported 
challenging treatment effects (Panel C and D). The majority re-
ported an increase in their awareness towards their sleep-wake 
rhythm, followed by a decrease in bedtime rumination (Panel 
E). Our observations confirmed that severely ill patients require 
substantive support, especially in dealing with adherence to the 
prescribed sleep window and daytime fatigue (Panel C and F). 
The health care providers reported that the overall additional 
effort surrounding SLEEPexpert was feasible, however, more ex-
tensive with severely affected patients. Table 2 provides quotes 
illustrating the evaluation of patients and health care providers.
Discussion
The main outcome of our project is the design and implemen-
tation of a novel pragmatic treatment program for insomnia 
in inpatient psychiatric care (“Become your own SLEEPexpert”). 
This extends prior work that mostly centered on insomnia in 
the absence of severe mental disorders. The development ap-
pears to be relevant since most patients with severe mental 
disorders suffer from comorbid insomnia. Our own clinical 
experience and data, in line with other work, shows that in-
somnia is often treated with hypnotics, comprising benzodi-
azepines or benzodiazepine receptor agonists, associated with 
the risk of tolerance and dependency. Our work shows that 
patients, some of them suffering from acute hallucinations 
or suicidality, as well as health care providers on psychiatric 
wards show a strong interest in non-pharmacological treat-
ment options. Of note, we show feasibility of implementation 
with existing resources in inpatient psychiatric care. The het-
erogeneity of the sample could indicate treatment feasibility 
across a broad spectrum of psychiatric disorders, yet further 
differentiation in terms of diagnosis was not feasible due to a 
small sample size.
The reported reduction of time in bed, increase of total sleep 
time and increase of sleep efficiency suggest an overall trend 
towards an improvement in insomnia severity and sleep con-
tinuity, although the PSQI as our measure for adherence offers 
a low resolution. Activity tracking was deemed less suitable due 
to the limited distinction of sleep from inactivity, common for 
patients with severe mental disorders [12]. Since the majority 
of patients reported chronic insomnia that withstood many 
years of treatment (insomnia duration > 10 years, intermittent/ 
persistent insomnia not defined), the observed improvement 
might at least partly be attributed to the SLEEPexpert interven-
tion. The adjustments made to the medication regimen suggest 
that the effects cannot be fully attributed to pharmacotherapy 
(Supplementary Table 1). Evaluative interviews provided infor-
mation about challenges in the hospital environment, rarely 
addressed in research. This included routines such as early 
dinner times (6 pm) and reduced activity opportunities in the 
evening, complicating adherence to delayed and restricted bed-
times. A supportive nursing team appears pivotal in supporting 
behavioral change.
The current treatment development represents an early step 
in the research-translation pathway. Future studies are required 
to investigate the mechanisms of sleep restriction therapy [24]. 
Importantly, future randomized, controlled, and powered trials 
are needed to test for safety and efficacy on insomnia and, po-
tentially other health-related outcomes. Follow-up assessments 
Table 2. Evaluative quotes from patients and health care providers
Patients
“I think it is very encouraging to see that there are people who take my problem (insomnia) seriously and support you throughout (therapy).”
“I did not expect that something as simple as a sleep window could alleviate the stress from having to sleep.”
“Through the bedtime restriction, I don‘t ruminate in bed as much as I used to.“  
“It is difficult to stay awake and keep myself occupied in the evenings, especially in the hospital.”
“I have been suffering from insomnia all my life, probably already in my mother’s womb. My anxiety towards sleep has since haunted me like an evil spirit. 
SLEEPexpert shed light on the spirit - and as spirits do, it dissolved in the light.”
Health care providers
“I especially liked the sleep window, I think this is a great treatment component.”  
“We appreciated the knowledge and experience that the program brought to the ward and the nursing team.”  
“SLEEPexpert was easy to understand and viable.”  
“We would recommend SLEEPexpert to other wards.”  
“Motivated patients are more likely to profit from the program.”  
“The biggest challenge was making the program compatible with the daily structure on the ward.”
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are required to shine light onto the effectiveness of the treat-
ment program after discharge of the clinic.
Together, the described line of research aims to result in a 
novel sleep-centered intervention that has the potential to be 
further implemented and disseminated in inpatient psychiatric 
care. An idea here is for clinicians to have the possibility to pre-
scribe a pragmatic non-pharmacological treatment package, as 
they would prescribe medication. We believe that the hospital 
stay represents a window of opportunity to reach out to pa-
tients who are otherwise difficult to support. SLEEPexpert could 
be considered as a starting point of a treatment chain, equip-
ping severely ill patients with tools for self-management of their 
sleep-wake behavior. This self-management of sleep-wake be-
havior could be supported by a smart-phone application in the 
future. Given the substantive burden of mental disorders and 
comorbid insomnia, further developments may fill the know-do 
gap and advance the management of insomnia in inpatient psy-
chiatric care.
Supplementary material
Supplementary material is available at SLEEP Advances online.
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